Japanese study checks blood thinner safety in leg artery patients
NCT ID NCT07142655
First seen Sep 30, 2025 · Last updated May 18, 2026 · Updated 24 times
Summary
This study looked at safety data from 1,500 people in Japan with peripheral artery disease (PAD) who had surgery to improve blood flow to their legs and were taking the blood thinner rivaroxaban. Researchers reviewed electronic health records to track bleeding events and heart-related deaths. The goal was to better understand the safety of rivaroxaban in this specific group, since earlier studies included few Japanese participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE (PAD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medical Data Vision Co., Ltd
Tokyo, 101-0053, Japan
Conditions
Explore the condition pages connected to this study.